Wealthfront Advisers LLC Pacific Biosciences Of California, Inc. Transaction History
Wealthfront Advisers LLC
- $38.2 Billion
- Q2 2025
A detailed history of Wealthfront Advisers LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 89,818 shares of PACB stock, worth $177,839. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,818
Previous 89,576
0.27%
Holding current value
$177,839
Previous $105,000
5.71%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PACB
# of Institutions
244Shares Held
202MCall Options Held
879KPut Options Held
847K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.3MShares$71.9 Million0.37% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$46.7 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$40.5 Million0.11% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA16.8MShares$33.2 Million2.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$31.7 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $445M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...